
Aasritha Thippavajjala
PharmD
Aasritha Thippavajjala is a pharm D student and aspiring medical writer with medical writing, clinical training experience and a strong interest in clinical research and patient safety She has hands-on exposure to clinical pharmacy activities including medication profile assessment, clinical case review, identification of potential drug-related problems, ADR awareness, patient counselling, and clinical documentation. She has also gained experience in medical literature review, evidence synthesis, and scientific communication through her published review article on digital twin-based patient simulation and her poster presentation at the 74th Indian Pharmaceutical Congress. Certified in ICH Good Clinical Practice (E6(R3)) and Scientific Writing in Health Research, she is passionate about applying her clinical knowledge and research skills to medical writing,clinical research and contributing to accurate, evidence-based healthcare.
About Aasritha
Aasritha Thippavajjala (PharmD) is a writer at Pharmacally, with 41 published articles, each checked against primary sources by our editorial team.
Articles by Aasritha Thippavajjala
Clinical TrialsEcopipam Shows Tic Reduction Through 18 Months in Tourette Syndrome
Health TidingsImmix Reports NXC-201 Shows 89% Complete Response in Amyloidosis Trial
Health TidingsIopofosine I 131 Shows 87.5% Response Rate in Waldenström Macroglobulinemia
Medical DevicesGammaTile Shows Superior Tumor Control and Overall Survival in Phase 3 ROADS Trial
Health TidingsTTX-MC138 Shows Sustained Disease Control in Phase 1a Trial
Clinical TrialsC4 Therapeutics Reports Biomarker Findings from Cemsidomide Studies in Multiple Myeloma
Health TidingsRemlifanserin Phase 2 Trial Narrowly Misses Primary Endpoint in Alzheimers Psychosis
Clinical TrialsORKA-001 Sustains Deep Psoriasis Clearance Through Week 28 After Two Doses
Clinical TrialsOtsuka Reports Positive Phase 3 FUSION Results in FUS-ALS
A. Musharaf Mohammad
Aabha Dey